Innoviva Profit Margin

The latest profit margin for INVA is 80.56% as of June 2026. That compares with 10.44% in the prior-year period — up 671.7% year over year. That is above the Healthcare sector average of 13.89%. Investors often review this figure alongside Innoviva's historical trend and sector peers before judging valuation or financial health.

Over the past year, INVA's profit margin moved from 10.44% to 80.56% — a 671.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Innoviva's valuation or profitability profile.

Against Healthcare companies, INVA currently prints 80.56% for profit margin, while the sector average sits near 13.89%. That is roughly 480.0% above the sector mean. Large gaps often invite a closer look at Innoviva's growth, margins, and balance sheet.

Profit Margin shows how effectively Innoviva converts resources into returns. At 80.56%, INVA may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 10.44% in the prior-year period — up 671.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting INVA's profit margin (80.56%), review year-over-year change from 10.44%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.